Ovid Therapeutics Inc. - Special Call

Core Viewpoint - Ovid Therapeutics is conducting a data call to discuss the Top Line OV329 Phase I readout, indicating progress in their clinical development efforts [2]. Group 1: Company Overview - The call is hosted by Victoria Fort, Senior Vice President of Corporate Affairs and Corporate Strategy, along with key executives including Dr. Jeremy Levin, Meg Alexander, Jeff Rona, and Zhong Zhong [2]. Group 2: Forward-Looking Statements - The company will be making forward-looking statements during the call, which are subject to risks and uncertainties that could lead to actual results differing from expectations [3].